Pri-Med Indianapolis

Indianapolis, IN | August 24, 2021

Indiana Convention Center

Disclosures

The following financial relationships have been disclosed by faculty. Relevant relationships will be disclosed at the start of each presentation, and all have been mitigated by Pri-Med Institute: 

Financial Disclosures

Katherine E. Galluzzi, DO, CMD, FACOFP
Information to come
Ty J. Gluckman, MD, FACC, FAHA
No relevant financial relationships disclosed.
Pamela Kushner, MD, FAAFP
AstraZeneca, Advisory Board; AstraZeneca, Consultant; AstraZeneca, Services Provided for Promotional Purposes (Not for CME/CE); AstraZeneca, Speakers Bureau; Boehringer Ingelheim, Consultant; Boehringer Ingelheim, Services Provided for Promotional Purposes (Not for CME/CE); Boehringer Ingelheim, Speakers Bureau; Janssen, Advisory Board; Janssen, Consultant; Janssen, Services Provided for Promotional Purposes (Not for CME/CE); Janssen, Speakers Bureau; Lilly, Consultant; Lilly, Services Provided for Promotional Purposes (Not for CME/CE); Lilly, Speakers Bureau; Novo Nordisk, Advisory Board; Novo Nordisk, Consultant; Novo Nordisk, Services Provided for Promotional Purposes (Not for CME/CE); Novo Nordisk, Speakers Bureau
Jeffrey Rado, MD, MPH, FAPA
Alkermes, Advisory Board; Alkermes, Acadia, Biogen, Roche, Otsuka, Lundbeck, Contracted Research; Alkernes, Speakers Bureau; Intracellular Therapies, Advisory Board; Lundbeck, Consultant
Rajeev Raghavan, MD
Information to come

Other Disclosures

Pamela Kushner, MD, FAAFP (Moderator and Content Reviewer): Financial relationships as listed above are relevant to the sessions which she is presenting, only. She has no relevant financial relationships for all other sessions at this conference. 

All other non-faculty contributors involved in the planning, development, editing and review of the content have disclosed no relevant financial relationships.